236 related articles for article (PubMed ID: 14583477)
1. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A
Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477
[TBL] [Abstract][Full Text] [Related]
2. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
[TBL] [Abstract][Full Text] [Related]
3. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
[TBL] [Abstract][Full Text] [Related]
4. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.
Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A
Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247
[TBL] [Abstract][Full Text] [Related]
5. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
6. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
7. The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42.
Cai D; Felekkis KN; Near RI; O'Neill GM; van Seventer JM; Golemis EA; Lerner A
J Immunol; 2003 Jan; 170(2):969-78. PubMed ID: 12517963
[TBL] [Abstract][Full Text] [Related]
8. A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT.
Ku GM; Yablonski D; Manser E; Lim L; Weiss A
EMBO J; 2001 Feb; 20(3):457-65. PubMed ID: 11157752
[TBL] [Abstract][Full Text] [Related]
9. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
Brinkman A; van der Flier S; Kok EM; Dorssers LC
J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
[TBL] [Abstract][Full Text] [Related]
10. Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.
Parrini MC; Lei M; Harrison SC; Mayer BJ
Mol Cell; 2002 Jan; 9(1):73-83. PubMed ID: 11804587
[TBL] [Abstract][Full Text] [Related]
11. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
12. BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.
Vanden Borre P; Near RI; Makkinje A; Mostoslavsky G; Lerner A
Cell Signal; 2011 Jun; 23(6):1030-40. PubMed ID: 21262352
[TBL] [Abstract][Full Text] [Related]
13. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization.
Papakonstanti EA; Stournaras C
Mol Biol Cell; 2002 Aug; 13(8):2946-62. PubMed ID: 12181358
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
Varma H; Conrad SE
Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
17. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics.
Edwards DC; Sanders LC; Bokoch GM; Gill GN
Nat Cell Biol; 1999 Sep; 1(5):253-9. PubMed ID: 10559936
[TBL] [Abstract][Full Text] [Related]
18. p21-activated kinase-1 (PAK1) inhibition of the human scavenger receptor class B, type I promoter in macrophages is independent of PAK1 kinase activity, but requires the GTPase-binding domain.
Hullinger TG; Panek RL; Xu X; Karathanasis SK
J Biol Chem; 2001 Dec; 276(50):46807-14. PubMed ID: 11585816
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
20. Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation.
Dadke D; Fryer BH; Golemis EA; Field J
Cancer Res; 2003 Dec; 63(24):8837-47. PubMed ID: 14695200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
